Cuixia Di

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Locally Advanced

Endoplasmic Reticulum Stress

Top Venues

Cell death & disease

Cell death discovery

Journal of cellular and molecular medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Zhihui Dou, Huiwen Lei, Wei Su, Taotao Zhang, Xiaohua Chen, Boyi Yu, Xiaogang Zhen, Jing Si, Chao Sun, Hong Zhang, Cuixia Di
Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell death & disease 15 (2) (2024)
Yue Hu, Zheng Li, Qiang Li, Xiaodong Jin, Cuixia Di, Weilan He, Xinran Cheng
Letter to the Editor: New confounders emerging with new evidence regarding reduced HCC and improved survival. Hepatology (Baltimore, Md.) (2024)
Zhihui Dou, Huiwen Lei, Wei Su, Taotao Zhang, Xiaohua Chen, Boyi Yu, Xiaogang Zhen, Jing Si, Chao Sun, Hong Zhang, Cuixia Di
Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell death & disease 15 (2) (2024)
Taotao Zhang, Huiwen Lei, Xiaohua Chen, Zhihui Dou, Boyi Yu, Wei Su, Wei Wang, Xiaodong Jin, Takanori Katsube, Bing Wang, Hong Zhang, Qiang Li, Cuixia Di
Carrier systems of radiopharmaceuticals and the application in cancer therapy. Cell death discovery 10 (1) (2024)
Zhihui Dou, Huiwen Lei, Wei Su, Taotao Zhang, Xiaohua Chen, Boyi Yu, Xiaogang Zhen, Jing Si, Chao Sun, Hong Zhang, Cuixia Di
Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell death & disease 15 (2) (2024)
Taotao Zhang, Huiwen Lei, Xiaohua Chen, Zhihui Dou, Boyi Yu, Wei Su, Wei Wang, Xiaodong Jin, Takanori Katsube, Bing Wang, Hong Zhang, Qiang Li, Cuixia Di
Carrier systems of radiopharmaceuticals and the application in cancer therapy. Cell death discovery 10 (1) (2024)
Zhihui Dou, Huiwen Lei, Wei Su, Taotao Zhang, Xiaohua Chen, Boyi Yu, Xiaogang Zhen, Jing Si, Chao Sun, Hong Zhang, Cuixia Di
Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell death & disease 15 (2) (2024)
Taotao Zhang, Huiwen Lei, Xiaohua Chen, Zhihui Dou, Boyi Yu, Wei Su, Wei Wang, Xiaodong Jin, Takanori Katsube, Bing Wang, Hong Zhang, Qiang Li, Cuixia Di
Carrier systems of radiopharmaceuticals and the application in cancer therapy. Cell death discovery 10 (1) (2024)
Jing Wang, Jiaxin Zhang, Qinglong Ma, Shasha Zhang, Fengdie Ma, Wei Su, Taotao Zhang, Xiaodong Xie, Cuixia Di
Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1-pRB-E2F1 pathway. Journal of cellular and molecular medicine (2023)
Jing Wang, Wei Su, Taotao Zhang, Shasha Zhang, Huiwen Lei, Fengdie Ma, Maoning Shi, Wenjing Shi, Xiaodong Xie, Cuixia Di
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation. Cell death & disease 14 (4) (2023)
Xiaohua Chen, Taotao Zhang, Wei Su, Zhihui Dou, Dapeng Zhao, Xiaodong Jin, Huiwen Lei, Jing Wang, Xiaodong Xie, Bo Cheng, Qiang Li, Hong Zhang, Cuixia Di
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell death & disease 13 (11) (2022)
Yuhong Chen, Zhihui Dou, Xiaohua Chen, Dapeng Zhao, Tuanjie Che, Wei Su, Tao Qu, Taotao Zhang, Caipeng Xu, Huiweng Lei, Qiang Li, Hong Zhang, Cuixia Di
Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells. Journal of cancer research and clinical oncology 148 (12) (2022)